Sirona Biochem Corp (V:SBM) — Stock Price
Sirona Biochem Corp (V:SBM) is currently trading at CA$0.06 CAD, up 0.00% today. Over the past 52 weeks, shares have ranged between CA$0.06 and CA$0.06. This page tracks Sirona Biochem Corp's live share price on the V exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Sirona Biochem Corp market cap and net worth.
Sirona Biochem Corp (SBM) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Sirona Biochem Corp's daily closing share price and trading volume on the V exchange over the past year, giving a clear view of recent price momentum and liquidity.
Sirona Biochem Corp Income Statement — Revenue, Profit & Earnings by Year
Sirona Biochem Corp's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Total Revenue | CA$34.78K | CA$671.92K | CA$268.02K | CA$105.71K | CA$135.74K |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | CA$135.74K |
| Research & Development | CA$1.20 Million | CA$1.08 Million | CA$1.15 Million | CA$1.31 Million | CA$1.26 Million |
| SG&A | CA$930.41K | CA$2.67 Million | CA$1.40 Million | CA$2.96 Million | CA$3.34 Million |
| Total Operating Expenses | CA$2.44 Million | CA$4.21 Million | CA$2.56 Million | CA$4.28 Million | CA$4.60 Million |
| Operating Income | CA$-2.41 Million | CA$-3.54 Million | CA$-2.30 Million | CA$-4.17 Million | CA$-4.47 Million |
| EBITDA | — | CA$-3.52 Million | CA$-2.30 Million | CA$-4.12 Million | CA$-4.44 Million |
| EBIT | — | CA$-3.39 Million | CA$-2.13 Million | CA$-4.00 Million | CA$-4.20 Million |
| Interest Expense | CA$201.65K | CA$27.00K | CA$3.33K | CA$13.13K | CA$116.74K |
| Income Before Tax | CA$-2.54 Million | CA$-3.55 Million | CA$-2.31 Million | CA$-4.14 Million | CA$-4.56 Million |
| Income Tax Expense | — | CA$5.95K | CA$-5.68K | CA$-7.08K | CA$-6.21K |
| Net Income | CA$-2.54 Million | CA$-3.56 Million | CA$-2.31 Million | CA$-4.13 Million | CA$-4.55 Million |
Sirona Biochem Corp Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Sirona Biochem Corp's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Total Assets | CA$1.03 Million | CA$1.29 Million | CA$1.29 Million | CA$2.14 Million | CA$4.26 Million |
| Total Current Assets | CA$1.02 Million | CA$1.27 Million | CA$1.26 Million | CA$2.10 Million | CA$4.26 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | CA$734.00 |
| Net Receivables | CA$6.61K | CA$23.89K | CA$55.89K | CA$107.15K | CA$456.80K |
| Inventory | — | — | — | — | — |
| Property, Plant & Equipment | — | CA$18.73K | CA$27.82K | CA$37.27K | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | CA$3.54 Million | CA$1.08 Million | CA$1.38 Million | CA$2.09 Million | CA$2.07 Million |
| Total Current Liabilities | CA$1.87 Million | CA$864.54K | CA$741.15K | CA$1.03 Million | CA$920.03K |
| Long-term Debt | CA$1.54 Million | CA$91.14K | CA$468.77K | CA$850.43K | CA$942.61K |
| Net Debt | CA$1.61 Million | CA$7.29K | — | — | — |
| Total Stockholder Equity | CA$-2.51 Million | CA$214.51K | CA$-97.02K | CA$47.40K | CA$2.19 Million |
| Retained Earnings | CA$-43.90 Million | CA$-41.36 Million | CA$-37.80 Million | CA$-35.49 Million | CA$-31.36 Million |
Sirona Biochem Corp Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Sirona Biochem Corp generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | CA$-1.76 Million | CA$-2.18 Million | CA$-2.16 Million | CA$-2.11 Million | CA$-3.56 Million |
| Capital Expenditures | CA$0.00 | CA$0.00 | CA$0.00 | CA$46.97K | CA$46.97K |
| Free Cash Flow | CA$-1.76 Million | CA$-2.18 Million | CA$-2.16 Million | CA$-2.16 Million | CA$-3.56 Million |
| Investing Cash Flow | — | — | — | CA$-46.97K | CA$-46.97K |
| Financing Cash Flow | CA$1.75 Million | CA$2.04 Million | CA$1.45 Million | CA$-45.96K | CA$6.96 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | CA$30.50K | CA$1.46 Million | CA$331.41K | CA$1.62 Million | CA$1.06 Million |
| Depreciation | CA$9.71K | CA$9.09K | CA$9.46K | CA$9.70K | CA$9.70K |
| Change in Cash | CA$-7.99K | CA$-356.49K | CA$-757.87K | CA$-2.20 Million | CA$3.40 Million |
Sirona Biochem Corp Earnings History — EPS Actual vs. Analyst Estimates
Track Sirona Biochem Corp's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Oct 28, 2025 | — | — | — |
| Jul 15, 2025 | — | — | — |
| Mar 31, 2025 | — | — | — |
| Jun 29, 2023 | 0.00 | — | — |
| Mar 29, 2023 | 0.00 | — | — |
| Sep 29, 2022 | 0.00 | — | — |
| Jun 28, 2022 | 0.00 | — | — |
| Mar 28, 2022 | 0.00 | — | — |